Table of Contents

Executive Summary

1 Industry Overview of Anti-infective Agents

• 1.1 Definition of Anti-infective Agents
• 1.2 Anti-infective Agents Segment by Type
  • 1.2.1 Global Anti-infective Agents Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Antibacterial Drugs
  • 1.2.3 Antifungal Drugs
  • 1.2.4 Antiviral Drugs
• 1.3 Anti-infective Agents Segment by Applications
  • 1.3.1 Global Anti-infective Agents Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital Use
  • 1.3.3 Clinic Use
  • 1.3.4 Household
  • 1.3.5 Other
• 1.4 Global Anti-infective Agents Overall Market
  • 1.4.1 Global Anti-infective Agents Revenue (2014-2025)
  • 1.4.2 Global Anti-infective Agents Production (2014-2025)
  • 1.4.3 North America Anti-infective Agents Status and Prospect (2014-2025)
  • 1.4.4 Europe Anti-infective Agents Status and Prospect (2014-2025)
  • 1.4.5 China Anti-infective Agents Status and Prospect (2014-2025)
  • 1.4.6 Japan Anti-infective Agents Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Anti-infective Agents Status and Prospect (2014-2025)
  • 1.4.8 India Anti-infective Agents Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Anti-infective Agents
• 2.3 Manufacturing Process Analysis of Anti-infective Agents
• 2.4 Industry Chain Structure of Anti-infective Agents

3 Development and Manufacturing Plants Analysis of Anti-infective Agents

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Anti-infective Agents Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Anti-infective Agents
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Anti-infective Agents Production and Capacity Analysis
• 4.2 Anti-infective Agents Revenue Analysis
• 4.3 Anti-infective Agents Price Analysis
• 4.4 Market Concentration Degree

5 Anti-infective Agents Regional Market Analysis

• 5.1 Anti-infective Agents Production by Regions
  • 5.1.1 Global Anti-infective Agents Production by Regions
  • 5.1.2 Global Anti-infective Agents Revenue by Regions
• 5.2 Anti-infective Agents Consumption by Regions
• 5.3 North America Anti-infective Agents Market Analysis
  • 5.3.1 North America Anti-infective Agents Production
  • 5.3.2 North America Anti-infective Agents Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Anti-infective Agents Import and Export
• 5.4 Europe Anti-infective Agents Market Analysis
  • 5.4.1 Europe Anti-infective Agents Production
  • 5.4.2 Europe Anti-infective Agents Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Anti-infective Agents Import and Export
• 5.5 China Anti-infective Agents Market Analysis
  • 5.5.1 China Anti-infective Agents Production
  • 5.5.2 China Anti-infective Agents Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Anti-infective Agents Import and Export
• 5.6 Japan Anti-infective Agents Market Analysis
  • 5.6.1 Japan Anti-infective Agents Production
  • 5.6.2 Japan Anti-infective Agents Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Anti-infective Agents Import and Export
• 5.7 Southeast Asia Anti-infective Agents Market Analysis
  • 5.7.1 Southeast Asia Anti-infective Agents Production
  • 5.7.2 Southeast Asia Anti-infective Agents Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Anti-infective Agents Import and Export
• 5.8 India Anti-infective Agents Market Analysis
  • 5.8.1 India Anti-infective Agents Production
  • 5.8.2 India Anti-infective Agents Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Anti-infective Agents Import and Export

6 Anti-infective Agents Segment Market Analysis (by Type)

• 6.1 Global Anti-infective Agents Production by Type
• 6.2 Global Anti-infective Agents Revenue by Type
• 6.3 Anti-infective Agents Price by Type

7 Anti-infective Agents Segment Market Analysis (by Application)

• 7.1 Global Anti-infective Agents Consumption by Application
• 7.2 Global Anti-infective Agents Consumption Market Share by Application (2014-2019)

8 Anti-infective Agents Major Manufacturers Analysis

• 8.1 Pfizer Inc.
  • 8.1.1 Pfizer Inc. Anti-infective Agents Production Sites and Area Served
  • 8.1.2 Pfizer Inc. Product Introduction, Application and Specification
  • 8.1.3 Pfizer Inc. Anti-infective Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Abbott Laboratories
  • 8.2.1 Abbott Laboratories Anti-infective Agents Production Sites and Area Served
  • 8.2.2 Abbott Laboratories Product Introduction, Application and Specification
  • 8.2.3 Abbott Laboratories Anti-infective Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Gilead Sciences, Inc.
  • 8.3.1 Gilead Sciences, Inc. Anti-infective Agents Production Sites and Area Served
  • 8.3.2 Gilead Sciences, Inc. Product Introduction, Application and Specification
  • 8.3.3 Gilead Sciences, Inc. Anti-infective Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Bristol-Myers Squibb Co.
  • 8.4.1 Bristol-Myers Squibb Co. Anti-infective Agents Production Sites and Area Served
  • 8.4.2 Bristol-Myers Squibb Co. Product Introduction, Application and Specification
  • 8.4.3 Bristol-Myers Squibb Co. Anti-infective Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Merck & Co., Inc.
  • 8.5.1 Merck & Co., Inc. Anti-infective Agents Production Sites and Area Served
  • 8.5.2 Merck & Co., Inc. Product Introduction, Application and Specification
  • 8.5.3 Merck & Co., Inc. Anti-infective Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Bayer Healthcare AG
  • 8.6.1 Bayer Healthcare AG Anti-infective Agents Production Sites and Area Served
  • 8.6.2 Bayer Healthcare AG Product Introduction, Application and Specification
  • 8.6.3 Bayer Healthcare AG Anti-infective Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 AstraZeneca Plc.
  • 8.7.1 AstraZeneca Plc. Anti-infective Agents Production Sites and Area Served
  • 8.7.2 AstraZeneca Plc. Product Introduction, Application and Specification
  • 8.7.3 AstraZeneca Plc. Anti-infective Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Boehringer Ingelheim
  • 8.8.1 Boehringer Ingelheim Anti-infective Agents Production Sites and Area Served
  • 8.8.2 Boehringer Ingelheim Product Introduction, Application and Specification
  • 8.8.3 Boehringer Ingelheim Anti-infective Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Novartis AG
  • 8.9.1 Novartis AG Anti-infective Agents Production Sites and Area Served
  • 8.9.2 Novartis AG Product Introduction, Application and Specification
  • 8.9.3 Novartis AG Anti-infective Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Astellas Pharma, Inc.
  • 8.10.1 Astellas Pharma, Inc. Anti-infective Agents Production Sites and Area Served
  • 8.10.2 Astellas Pharma, Inc. Product Introduction, Application and Specification
  • 8.10.3 Astellas Pharma, Inc. Anti-infective Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 GlaxoSmithKline Plc.
• 8.12 Alcon Pharmaceuticals Ltd.
• 8.13 Sanofi-Aventis S.A.
• 8.14 Johnson & Johnson

9 Development Trend of Analysis of Anti-infective Agents Market

• 9.1 Global Anti-infective Agents Market Trend Analysis
  • 9.1.1 Global Anti-infective Agents Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Anti-infective Agents Regional Market Trend
  • 9.2.1 North America Anti-infective Agents Forecast 2019-2025
  • 9.2.2 Europe Anti-infective Agents Forecast 2019-2025
  • 9.2.3 China Anti-infective Agents Forecast 2019-2025
  • 9.2.4 Japan Anti-infective Agents Forecast 2019-2025
  • 9.2.5 Southeast Asia Anti-infective Agents Forecast 2019-2025
  • 9.2.6 India Anti-infective Agents Forecast 2019-2025
• 9.3 Anti-infective Agents Market Trend (Product Type)
• 9.4 Anti-infective Agents Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Anti-infective Agents Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites. Infections thus caused can be classified depending on type of organism causing the infection and symptoms and medical signs shown by the host.
North America was one of the dominated countries in 2015 with a revenue generation of over USD 26.3 billion. The presence of sophisticated healthcare infrastructure and high awareness amongst the end-users such as clinicians and healthcare professionals in this region are estimated to be the key factors contributing to this large share. Moreover, in this region, the high purchasing power of expensive drugs and the presence of favorablereimbursement policies are the drivers projected to accentuate the growth of the anti-infective agents market.
Asia-Pacific is expected to witness significant growth over the forecast period owing to the presence of generics companies, the rising economic stability, and the increasing level of disposable income. In addition, the growing geriatric population base coupled with the increased susceptibility to infections is expected to provide a potential growth platform to this industry.

The global Anti-infective Agents market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-infective Agents volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-infective Agents market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-infective Agents in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-infective Agents manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer Inc.
Abbott Laboratories
Gilead Sciences, Inc.
Bristol-Myers Squibb Co.
Merck & Co., Inc.
Bayer Healthcare AG
AstraZeneca Plc.
Boehringer Ingelheim
Novartis AG
Astellas Pharma, Inc.
GlaxoSmithKline Plc.
Alcon Pharmaceuticals Ltd.
Sanofi-Aventis S.A.
Johnson & Johnson

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs

Segment by Application
Hospital Use
Clinic Use
Household
Other